Market Insights
Stay Up-to-Date With the Latest News in the Targeted Protein Degradation Field.
Browse Our Exclusive Content Below
TPD Press Releases
Explore the press releases from the 5th TPD Summit!
Expect many more press releases this year, with lots of new data to be shared by 100+ experts.
An Exclusive Interview With:
Jennifer Johnston, Co-Founder & Chief Executive Officer, NysnoBio
The TPD Landscape: A Review
Conducted by Beacon Targeted Therapies
Nurix Interview
5th Targeted Protein Degradation Summit
Hear from Arthur T. Sands, M.D., Ph.D., president and CEO of Nurix Therapeutics, as he shares his thoughts on the TPD field and why he’s excited about the upcoming conference. He also gives a sneak peek to what he and the Nurix team will be presenting next month.
<< Check out the full interview here
Beacon Brainstorms Podcast:
Alessio Ciulli on Drug Design and the Future of TPD
Sofia Rodriguez talks to Alessio Ciulli, professor of chemical structural biology at the University of Dundee and Co-Founder of Amphista Therapeutics, the leading Europe-based TPD company. Join us to hear about his lab's ground-breaking research into protein degradation, the opening of the new Centre for Targeted Protein Degradation (CeTPD), and the opportunities and challenges of novel degrader design.
